Nucleai

Revolutionizing Clinical Trials with Spatial AI for Biomarker Analysis

Our series of videos introduces Nucleai's groundbreaking technology as the first spatial AI tool empowering pathologists in clinical trial patient selection, directly linked to drug development programs. With a pioneering platform for AI-driven spatial biomarker analysis, we offer a unique multimodal solution. By processing images from diverse modalities and conducting advanced spatial analysis, Nucleai delivers actionable insights. These insights optimize biomarker scoring, unveil prevalence and mechanisms of action, and predict therapy response, reshaping disease diagnosis and treatment paradigms.

Client - Nucleai

Directors, Script - Yahel Yakov, Tomer Levine

Producer - Yahel Yakov

DOP - Tomer Levine

Editor - Adi Gabay